financetom
Business
financetom
/
Business
/
Guidewire Software Insider Sold Shares Worth $303,114, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Guidewire Software Insider Sold Shares Worth $303,114, According to a Recent SEC Filing
May 26, 2025 8:05 AM

04:22 PM EDT, 05/14/2025 (MT Newswires) -- Michael George Rosenbaum, Director, Chief Executive Officer, on May 12, 2025, sold 1,400 shares in Guidewire Software ( GWRE ) for $303,114. Following the Form 4 filing with the SEC, Rosenbaum has control over a total of 251,593 common shares of the company, with 251,593 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1528396/000152839625000113/xslF345X05/wk-form4_1747252877.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
Sep 8, 2025
Sept 8 (Reuters) - ElevenLabs is letting employees sell shares at a valuation of $6.6 billion - double the voice cloning artificial intelligence startup's previous value, Bloomberg News reported on Monday. ElevenLabs had raised $180 million in its last funding round in January which gave it a valuation of $3.3 billion at the time. AI startups engaged in a fierce...
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
Sep 8, 2025
(Reuters) -ElevenLabs is letting employees sell shares at a valuation of $6.6 billion - double the voice cloning artificial intelligence startup's previous value, Bloomberg News reported on Monday. ElevenLabs had raised $180 million in its last funding round in January which gave it a valuation of $3.3 billion at the time. AI startups engaged in a fierce competition for talent...
DexCom Faces Organic Issues, Competition Threat Despite 'Doing Everything' to Topple Headwinds, Oppenheimer Says
DexCom Faces Organic Issues, Competition Threat Despite 'Doing Everything' to Topple Headwinds, Oppenheimer Says
Sep 8, 2025
11:10 AM EDT, 09/08/2025 (MT Newswires) -- DexCom ( DXCM ) is facing organic issues and a competition threat despite doing everything to overcome multiple challenges, Oppenheimer said in a Monday note. The performance of the company's G7-10D glucose monitoring system is facing patients' concerns due to poor accuracy, failed sensor insertions, abrupt stoppages, and other issues, the analysts said....
Boston Scientific Outperforming MedTech Sector Driven by Electophysiology Business, Oppenheimer Says
Boston Scientific Outperforming MedTech Sector Driven by Electophysiology Business, Oppenheimer Says
Sep 8, 2025
10:47 AM EDT, 09/08/2025 (MT Newswires) -- Boston Scientific ( BSX ) is outperforming the medical technology sector, with growth over the past year driven by its electophysiology business, Oppenheimer said in a Monday note. BSX represents one of the best large-cap medtech growth stories, driven by disciplined mergers and acquisitions and strong execution, most obviously in the [electophysiology] franchise,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved